Veradigm

News

ESC 2024: Obesity drugs emerge as attractive tool for heart failure prevention

Experts discuss the relationship between obesity and heart failure while referencing new clinical trial results.

Irena Maragkou

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Sections

Sections

Sections

Sections

Sections

ESC 2024: Obesity drugs emerge as attractive tool for heart failure prevention

Leading Artificial Intelligence (AI) Companies in Pharma

Leading Strategic Intelligence Solutions for the Pharmaceutical Industry

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief